Abstract:GATA2 coding and noncoding germline mutations cause GATA2 deficiency syndrome, often leading to myelodysplastic syndrome and acute myeloid leukemia. We demonstrated that GATA2 deficiency in murine fetal liver progenitors resulting from loss of Gata2 -77 enhancer upregulates components of Interferon-gamma (IFNg) and Toll-like receptor (TLR) signaling pathways. Using a genetic rescue system, we demonstrated that GATA2-deficient fetal progenitors are hypersensitive to IFNg and TLR1/2 agonist through signaling crosstalk to establish an aberrant transcriptional state. This elevated innate immune signaling is associated with disrupted hematopoiesis and retention of monocytic differentiation ex vivo. GATA2 deficiency elevated expression of select B-lineage and myeloid genes via a PU.1-dependent mechanism. To test the hypothesis that PU.1 is required to establish an ectopic signaling state in GATA2-deficient progenitors, we deleted Spi1 -14 kb enhancer, reducing PU.1 expression ∼50%, and tested whether PU.1 is critical, contributory, or not required for IFNg- and TLR-dependent genomic responses. RNA-seq analysis revealed that PU.1 loss abrogated TLR1/2-dependent transcriptional regulation. By contrast, PU.1 loss attenuated certain, but not all, IFNg-mediated transcriptional responses or responses to synergistic signaling. Multiomic studies are parsing GATA2 and PU.1 target genes as signal-dependent or -independent and establishing mechanisms rendering a given gene regulated by GATA2, PU.1, individual pathways, and/or synergistic signaling. In aggregate, these studies support a model in which GATA2 levels dictate genome responsiveness to the innate immune signaling milieu, and elucidating the mechanisms will unveil new concepts of how hematopoietic regulators dictate genome responsiveness to a dynamically changing signaling environment in physiological and pathologic contexts.

The emerging role of GATA transcription factors in development and disease

GATA transcription factors in development and disease

The role of GATA family transcriptional factors in haematological malignancies: A review

The Function of GATA Family in Cell Fate Determination

GATA transcription factors in vertebrates: evolutionary, structural and functional interplay

From embryogenesis to adulthood: Critical role for GATA factors in heart development and function

Distinct Functions for the Transcription Factors GATA-3 and ThPOK During Intrathymic Differentiation of CD4+ T Cells

GATA6 defines endoderm fate by controlling chromatin accessibility during differentiation of human-induced pluripotent stem cells

The Roles of GATA-4 During the Heart Development of Vertebrates

Evolution of Developmental GATA Factors in Nematodes

The research progress of GATA6 in heart development and isolated atrial septal defect

GATA-2 Regulates Granulocyte-Macrophage Progenitor Cell Function.

Dynamic Regulation of GATA2 in Fate Determination in Hematopoiesis: Possible Approach to Hpsc-Derived Hematopoietic Stem/progenitor Cells

Cell fate determination is associated with changes in competing transcriptional units in the human GATA1 and GATA2 lineage-determining transcription factors

Gata2 +9.5 Enhancer Regulates Adult Hematopoietic Stem Cell Self-Renewal and T-cell Development.

GATA2 −/− human ESCs undergo attenuated endothelial to hematopoietic transition and thereafter granulocyte commitment

Molecular Evolution of the GATA Family of Transcription Factors: Conservation Within the DNA-Binding Domain

[GATA factor-related hematopoietic neoplasms]

Hematological phenotypes in GATA2 deficiency syndrome arise from secondary injuries and maladaptation to proliferation

3010 – MOLECULAR DETERMINANTS OF INNATE IMMUNE SIGNAL-DEPENDENT GENOME RESPONSIVENESS IN HEMATOPOIETIC PROGENITOR CELLS

Regulation of GATA4 Transcriptional Activity in Cardiovascular Development and Disease.